We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A once-daily regimen of the oral beta3-adrenoceptor (AR) agonist vibegron is effective in the treatment of overactive bladder, including elderly populations, according to results of the phase 3 EMPOWUR trial ...